Dechra Pharmaceuticals PLC
LSE:DPH
Dechra Pharmaceuticals PLC
LSE:DPH
Price:
3 866 GBX
Updated:
May 10, 2024
Dechra Pharmaceuticals PLC
Operating Income
|
Dechra Pharmaceuticals PLC
Operating Income Peer Comparison
Comparables:
GSK
AZN
VRNA
INDV
HIK
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Operating Income
£24.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Operating Income
£7.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Operating Income
$8.6B
|
CAGR 3-Years
27%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Operating Income
-$67.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Operating Income
$257m
|
CAGR 3-Years
20%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Operating Income
$622m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is Dechra Pharmaceuticals PLC's Operating Income?
Operating Income
24.9m
GBP
24.9m
GBP
Based on the financial report for Jun 30, 2023, Dechra Pharmaceuticals PLC's Operating Income amounts to 24.9m GBP.
What is Dechra Pharmaceuticals PLC's Operating Income growth rate?
Operating Income CAGR 10Y
3%
3%
Over the last year, the Operating Income growth was -75%. The average annual Operating Income growth rates for Dechra Pharmaceuticals PLC have been -25% over the past three years , -11% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
